제리스 바이오파마 홀딩스, Inc.
DE ˙ DB ˙ US98422E1038
€5.20 ↑0.22 (4.40%)
2026-06-05
주가
SecurityDE:2B30 / Xeris Biopharma Holdings, Inc.
InstitutionIHT Wealth Management, LLC
Latest Disclosed Ownership376,476 shares
Latest Disclosed Value $ 2,183,561
IHT Wealth Management, LLC reports 42.86% increase in ownership of 2B30 / Xeris Biopharma Holdings, Inc.

On May 15, 2026 - IHT Wealth Management, LLC filed a 13F-HR form disclosing ownership of 376,476 shares of Xeris Biopharma Holdings, Inc. (DE:2B30) valued at $1,815,367 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 263,531 shares of Xeris Biopharma Holdings, Inc.. This represents a change in shares of 42.86% during the quarter. The current value of the position is $1,957,675 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F Xeris Biopharma Holdings COM 98422E103 376,476 112,945 42.86 2,184 5.56 0.0505
2026-02-17 2025-12-31 13F Xeris Biopharma Holdings COM 98422E103 263,531 5,356 2.07 2,069 -1.57 0.0503
2025-11-14 2025-09-30 13F Xeris Biopharma Holdings COM 98422E103 258,175 -5,630 -2.13 2,102 70.67 0.0532
2025-08-14 2025-06-30 13F Xeris Biopharma Holdings COM 98422E103 263,805 1,000 0.38 1,232 -14.63 0.0339
2025-05-15 2025-03-31 13F Xeris Biopharma Holdings COM 98422E103 262,805 -7,355 -2.72 1,443 57.60 0.0451
2025-02-14 2024-12-31 13F Xeris Biopharma Holdings COM 98422E103 270,160 -6,725 -2.43 916 15.97 0.0295
2024-11-14 2024-09-30 13F Xeris Biopharma Holdings COM 98422E103 276,885 -19,450 -6.56 789 18.47 0.0224
2024-08-14 2024-06-30 13F XERIS BIOPHARMA COM 98422E103 296,335 -2,032 -0.68 667 1.06 0.0249
2024-05-15 2024-03-31 13F Xeris Biopharma Holdings COM 98422E103 298,367 18,975 6.79 659 0.46 0.0264
2024-02-14 2023-12-31 13F XERIS BIOPHARMA COM 98422E103 279,392 -5,000 -1.76 657 24.24 0.0293
2023-11-14 2023-09-30 13F XERIS BIOPHARMA COM 98422E103 284,392 2,950 1.05 529 -28.36 0.0268
2023-08-15 2023-06-30 13F XERIS BIOPHARMA COM 98422E103 281,442 0 0.00 737 60.92 0.0384
2023-05-15 2023-03-31 13F XERIS BIOPHARMA COM 98422E103 281,442 -15,425 -5.20 459 16.24 0.0262
2023-02-15 2022-12-31 13F XERIS BIOPHARMA COM 98422E103 296,867 -38,420 -11.46 395 -24.67 0.0248
2022-11-22 2022-09-30 13F XERIS BIOPHARMA COM 98422E103 335,287 -2,100 -0.62 523 0.58 0.0397
2022-08-15 2022-06-30 13F XERIS BIOPHARMA COM 98422E103 337,387 337,387 520 0.0458
2022-05-16 2022-03-31 13F XERIS BIOPHARMA COM 98422E103 0 -342,897 -100.00 0 -100.00
2022-02-14 2021-12-31 13F XERIS BIOPHARMA COM 98422E103 342,897 342,897 1,005 0.0741
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.